FOTOBIOMODULYATSIYANING MIASTENIYA KOMPLEKS DAVOSIDAGI O‘RNI, UNING DAVOLASH NATIJALARIGA VA IMMUN-YALLIG‘LANISH KO‘RSATKICHLARIGA TA’SIRI
;
miasteniya gravis, fotobiomodulyatsiya, immun-yallig‘lanish markerlari, kognitiv funksiyalar, dori vositalarisiz davolash.Abstrak
Miasteniya — bu surunkali autoimmun kasallik bo‘lib, uning asosida nerv-mushak uzatilishining buzilishi yotadi. Natijada mushak zaifligi, tez charchash va hayot uchun xavfli asoratlar rivojlanishi mumkin. Farmakologik terapiyadagi yutuqlarga qaramay, davolash samaradorligini oshirish, nojo‘ya ta’sirlarni kamaytirish va bemorlarning hayot sifatini yaxshilashga qaratilgan qo‘shimcha yondashuvlarga ehtiyoj saqlanib qolmoqda. Shunday istiqbolli yo‘nalishlardan biri fotobiomodulyatsiya (FBM) hisoblanadi — u past intensivlikdagi lazer yoki LED nurlanishidan foydalanishga asoslangan fizioterapiya usuli. So‘nggi yillarda FBM nevrologiya va immunologiya sohalarida faol o‘rganilmoqda, chunki u mitoxondrial faoliyatni modulyatsiya qilish, yallig‘lanish jarayonlarini kamaytirish va kognitiv funksiyalarni qo‘llab-quvvatlash qobiliyatiga ega. Ushbu maqolada miasteniyada FBMning potentsial mexanizmlari va klinik ta’sirlari hamda kasallik faolligi bilan bog‘liq immun-yallig‘lanish markerlariga mumkin bo‘lgan ta’siri ko‘rib chiqiladi.
Iqtiboslar
Вейн А.М., Гусев Е.И. Неврология: национальное руководство. — М.: ГЭОТАР-Медиа, 2022. — 816 с.
Бабаян А.А., Давидян С.А., Арутюнян И.Н. Современные возможности низкоинтенсивной лазерной терапии в клинической практике // Вестник восстановительной медицины. — 2021. — №3. — С. 42–47.
Bicknell B., Liebert A., Kiat H. Neuroprotective mechanisms of photobiomodulation: evidence from pre-clinical and clinical studies // Molecular Neurobiology. — 2021. — Vol. 58(5). — P. 2237–2259. https://doi.org/10.1007/s12035-020-02267-4
Hamblin M.R. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation // AIMS Biophysics. — 2017. — Vol. 4(3). — P. 337–361. https://doi.org/10.3934/biophy.2017.3.337
Karu T.I. Mitochondrial signaling in mammalian cells activated by red and near-IR radiation // Photochemistry and Photobiology. — 2008. — Vol. 84(5). — P. 1091–1099. https://doi.org/10.1111/j.1751-1097.2008.00394.x
Huang Y.Y., Sharma S.K., Carroll J., Hamblin M.R. Biphasic dose response in low level light therapy // Dose-Response. — 2011. — Vol. 9(4). — P. 602–618. https://doi.org/10.2203/dose-response.11-027.Hamblin
Salehpour F., Cassano P., Chang M., Hamblin M.R. Near-infrared photobiomodulation in neurodegenerative diseases: a systematic review of randomized controlled trials // Aging and Disease. — 2020. — Vol. 11(2). — P. 302–321. https://doi.org/10.14336/AD.2019.0610
Naeser M.A., Saltmarche A., Krengel M.H., et al. Improved cognitive function after transcranial LED treatments in chronic traumatic brain injury: two case reports // Photomedicine and Laser Surgery. — 2011. — Vol. 29(5). — P. 351–358. https://doi.org/10.1089/pho.2010.2814
Gupta A., Dai T., Hamblin M.R. Effect of red and near-infrared wavelengths on wound healing: clinical and experimental findings // Lasers in Surgery and Medicine. — 2014. — Vol. 46(2). — P. 89–97. https://doi.org/10.1002/lsm.22191
Khan I., Arany P.R. Photobiomodulation therapy for tissue healing: pathophysiology and mechanisms // Journal of Dental Research. — 2015. — Vol. 94(9). — P. 1177–1186. https://doi.org/10.1177/0022034515593597
Chung H., Dai T., Sharma S.K., et al. The nuts and bolts of low-level laser therapy // Annals of Biomedical Engineering. — 2012. — Vol. 40(2). — P. 516–533. https://doi.org/10.1007/s10439-011-0454-7
Almutairi A., Mahir A., Alqurashi M., et al. Efficacy of photobiomodulation for muscle performance and recovery: a systematic review and meta-analysis // Lasers in Medical Science. — 2022. — Vol. 37. — P. 1287–1301. https://doi.org/10.1007/s10103-021-03312-4
Lan C.H., Hsu S.P., Cheng M.C. Application of intravascular laser irradiation of blood in a patient with refractory myasthenia gravis: a case report // World Journal of Clinical Cases. — 2022. — Vol. 10(6). — P. 2023–2028. https://doi.org/10.12998/wjcc.v10.i6.2023
Baybekov I., Mustafakulov Kh., Rasulov F. Laser therapy and plasmapheresis in myasthenia gravis: effects on erythrocytes and endothelium // Proceedings of SPIE. — 2010. — Vol. 7547. — P. 75470C. https://doi.org/10.1117/12.849960
Zhou Y., Guo M., Wang J., et al. Extracellular vesicles carrying caspase-1 inhibitors alleviate symptoms of experimental autoimmune myasthenia gravis // Journal of Controlled Release. — 2023. — Vol. 360. — P. 12–25. https://doi.org/10.1016/j.jconrel.2023.05.006
Alchinova I.B., Lysenko L.A., et al. Laser correlation spectroscopy in diagnostics of myasthenia gravis // Journal of Biomedical Optics. — 2014. — Vol. 19(2). — P. 021103. https://doi.org/10.1117/1.JBO.19.2.021103
Stefaniotou M., Tranos P., Kotsolis A., et al. Central serous chorioretinopathy after corticosteroid therapy for myasthenia gravis: treatment with argon laser photocoagulation // Case Reports in Ophthalmology. — 2013. — Vol. 4(2). — P. 112–117. https://doi.org/10.1159/000351440
Huang H., Zhang L., et al. Low-level laser therapy in experimental autoimmune myasthenia gravis: mitochondrial modulation // Neural Regeneration Research. — 2016. — Vol. 11(30). — P. 1898–1905. https://doi.org/10.4103/1673-5374.193237
Lopes-Martins R.A., Marcos R.L., et al. Photobiomodulation in sports medicine: therapeutic approach for performance and recovery // British Journal of Sports Medicine. — 2018. — Vol. 52(10). — P. 595–596. https://doi.org/10.1136/bjsports-2017-098272
Barolet D., Christiaens F., Hamblin M.R. Infrared and near-infrared photobiomodulation for cognitive improvement: evidence, mechanisms, and future directions // Ageing Research Reviews. — 2021. — Vol. 70. — P. 101389. https://doi.org/10.1016/j.arr.2021.101389
